Gina Mazzariello - Net Worth and Insider Trading
Gina Mazzariello Net Worth
The estimated net worth of Gina Mazzariello is at least $817,665 dollars as of 2025-05-15. Gina Mazzariello is the Chief Legal Officer of Amylyx Pharmaceuticals Inc and owns about 187,969 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $817,665. Details can be seen in Gina Mazzariello's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gina Mazzariello has not made any transactions after 2025-03-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gina Mazzariello
Gina Mazzariello Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gina Mazzariello owns 1 companies in total, including Amylyx Pharmaceuticals Inc (AMLX) .
Click here to see the complete history of Gina Mazzariello’s form 4 insider trades.
Insider Ownership Summary of Gina Mazzariello
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals Inc | 2025-03-31 | Chief Legal Officer |
Gina Mazzariello Latest Holdings Summary
Gina Mazzariello currently owns a total of 1 stock. Gina Mazzariello owns 187,969 shares of Amylyx Pharmaceuticals Inc (AMLX) as of March 31, 2025, with a value of $817,665.
Latest Holdings of Gina Mazzariello
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals Inc | 2025-03-31 | 187,969 | 4.35 | 817,665 |
Holding Weightings of Gina Mazzariello
Gina Mazzariello Form 4 Trading Tracker
According to the SEC Form 4 filings, Gina Mazzariello has made a total of 10 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the sale of 9,192 shares on March 31, 2025, which brought Gina Mazzariello around $31,988.
Insider Trading History of Gina Mazzariello
- 1
Gina Mazzariello Trading Performance
Gina Mazzariello Ownership Network
Ownership Network List of Gina Mazzariello
Ownership Network Relation of Gina Mazzariello
Gina Mazzariello Owned Company Details
What does Amylyx Pharmaceuticals Inc do?
Who are the key executives at Amylyx Pharmaceuticals Inc?
Gina Mazzariello is the Chief Legal Officer of Amylyx Pharmaceuticals Inc. Other key executives at Amylyx Pharmaceuticals Inc include director & Co-Chief Executive Officer Joshua B Cohen , director & Co-Chief Executive Officer Justin B. Klee , and Chief Financial Officer James M Frates .
Amylyx Pharmaceuticals Inc (AMLX) Insider Trades Summary
Over the past 18 months, Gina Mazzariello made 8 insider transaction in Amylyx Pharmaceuticals Inc (AMLX) with a net sale of 42,192. Other recent insider transactions involving Amylyx Pharmaceuticals Inc (AMLX) include a net sale of 73,976 shares made by Justin B. Klee , a net sale of 73,972 shares made by Joshua B Cohen , and a net purchase of 24,596 shares made by James M Frates .
In summary, during the past 3 months, insiders sold 90,463 shares of Amylyx Pharmaceuticals Inc (AMLX) in total and bought 10,000 shares, with a net sale of 80,463 shares. During the past 18 months, 237,644 shares of Amylyx Pharmaceuticals Inc (AMLX) were sold and 209,000 shares were bought by its insiders, resulting in a net sale of 28,644 shares.
Amylyx Pharmaceuticals Inc (AMLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amylyx Pharmaceuticals Inc Insider Transactions
Gina Mazzariello Mailing Address
Above is the net worth, insider trading, and ownership report for Gina Mazzariello. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Gina Mazzariello's mailing address is: Cambridge Ma 02141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
